Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran

Background The epidemiology of inflammatory bowel disease (IBD) is changing globally and there is disagreement between studies about the prevalence of relapse of ulcerative colitis (UC) as a type of IBD. Objectives The current study aimed to find out the incidence of relapses in patients with U...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Seyed Vahid Hosseini, Seyed Alireza Taghavi, Peyman Jafari, Abbas Rezaianzadeh, Maryam Moini, Manoosh Mehrabi, Masood Sepehrimanesh, Ali Reza Safarpour
Formato:	article
Lenguaje:	EN
Publicado:	Shiraz University of Medical Sciences 2016
Materias:	ulcerative colitis relapse mesalazin incidence Medicine R
Acceso en línea:	https://doaj.org/article/af12050031b84ca1be4d3c8b2bec4407
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:af12050031b84ca1be4d3c8b2bec4407
record_format	dspace
spelling	oai:doaj.org-article:af12050031b84ca1be4d3c8b2bec44072021-11-15T09:43:49ZIncidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran2783-243010.17795/acr-34565https://doaj.org/article/af12050031b84ca1be4d3c8b2bec44072016-03-01T00:00:00Zhttps://colorectalresearch.sums.ac.ir/article_45509_e4e334b3b1a5c0416cc0800de07c844c.pdfhttps://doaj.org/toc/2783-2430Background The epidemiology of inflammatory bowel disease (IBD) is changing globally and there is disagreement between studies about the prevalence of relapse of ulcerative colitis (UC) as a type of IBD. Objectives The current study aimed to find out the incidence of relapses in patients with UC in Southern Iran. Patients and Methods In a prospective cohort study in a period of one year (from October 2012 to October 2013) 157 patients with UC who were in clinical remission for at least three months and were registered in the IBD registry of Shiraz University of Medical Sciences, Shiraz, Iran were enrolled. The sample size was calculated according to the formula to determine a ratio. Clinical relapse was described as deterioration of bowel movements, lower intestinal bleeding or worsening of abdominal pain and diarrhea leading to changes in previous treatment. Age and gender distribution and the frequency of relapse in a one-year follow-up were recorded. Results Among the 1273 registered patients with UC, 157 patients were enrolled in the survey by systematic sampling. Among patients, 48.7% were female and no significant difference was observed between the mean age of two gender groups (P = 0.70). Seventy-four patients, 48.1% (33 males and 41 females), relapsed during the 12-month follow-up period and the main medication of the 64 non-relapsing (80%) and 62 relapsing (83.8%) patients was mesalazin (P = 0.65). Conclusions Although, the reported incidence was almost equal to previous reports from other regions of the world, relapsed and non-relapsed UC patients received mesalazin as treatment without any significant differences.Seyed Vahid HosseiniSeyed Alireza TaghaviPeyman JafariAbbas RezaianzadehMaryam MoiniManoosh MehrabiMasood SepehrimaneshAli Reza SafarpourShiraz University of Medical Sciencesarticleulcerative colitisrelapsemesalazinincidenceMedicineRENIranian Journal of Colorectal Research, Vol 4, Iss 1, Pp 0-0 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	ulcerative colitis relapse mesalazin incidence Medicine R
spellingShingle	ulcerative colitis relapse mesalazin incidence Medicine R Seyed Vahid Hosseini Seyed Alireza Taghavi Peyman Jafari Abbas Rezaianzadeh Maryam Moini Manoosh Mehrabi Masood Sepehrimanesh Ali Reza Safarpour Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran
description	Background The epidemiology of inflammatory bowel disease (IBD) is changing globally and there is disagreement between studies about the prevalence of relapse of ulcerative colitis (UC) as a type of IBD. Objectives The current study aimed to find out the incidence of relapses in patients with UC in Southern Iran. Patients and Methods In a prospective cohort study in a period of one year (from October 2012 to October 2013) 157 patients with UC who were in clinical remission for at least three months and were registered in the IBD registry of Shiraz University of Medical Sciences, Shiraz, Iran were enrolled. The sample size was calculated according to the formula to determine a ratio. Clinical relapse was described as deterioration of bowel movements, lower intestinal bleeding or worsening of abdominal pain and diarrhea leading to changes in previous treatment. Age and gender distribution and the frequency of relapse in a one-year follow-up were recorded. Results Among the 1273 registered patients with UC, 157 patients were enrolled in the survey by systematic sampling. Among patients, 48.7% were female and no significant difference was observed between the mean age of two gender groups (P = 0.70). Seventy-four patients, 48.1% (33 males and 41 females), relapsed during the 12-month follow-up period and the main medication of the 64 non-relapsing (80%) and 62 relapsing (83.8%) patients was mesalazin (P = 0.65). Conclusions Although, the reported incidence was almost equal to previous reports from other regions of the world, relapsed and non-relapsed UC patients received mesalazin as treatment without any significant differences.
format	article
author	Seyed Vahid Hosseini Seyed Alireza Taghavi Peyman Jafari Abbas Rezaianzadeh Maryam Moini Manoosh Mehrabi Masood Sepehrimanesh Ali Reza Safarpour
author_facet	Seyed Vahid Hosseini Seyed Alireza Taghavi Peyman Jafari Abbas Rezaianzadeh Maryam Moini Manoosh Mehrabi Masood Sepehrimanesh Ali Reza Safarpour
author_sort	Seyed Vahid Hosseini
title	Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran
title_short	Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran
title_full	Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran
title_fullStr	Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran
title_full_unstemmed	Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran
title_sort	incidence of ulcerative colitis relapse: a prospective cohort study in southern iran
publisher	Shiraz University of Medical Sciences
publishDate	2016
url	https://doaj.org/article/af12050031b84ca1be4d3c8b2bec4407
work_keys_str_mv	AT seyedvahidhosseini incidenceofulcerativecolitisrelapseaprospectivecohortstudyinsoutherniran AT seyedalirezataghavi incidenceofulcerativecolitisrelapseaprospectivecohortstudyinsoutherniran AT peymanjafari incidenceofulcerativecolitisrelapseaprospectivecohortstudyinsoutherniran AT abbasrezaianzadeh incidenceofulcerativecolitisrelapseaprospectivecohortstudyinsoutherniran AT maryammoini incidenceofulcerativecolitisrelapseaprospectivecohortstudyinsoutherniran AT manooshmehrabi incidenceofulcerativecolitisrelapseaprospectivecohortstudyinsoutherniran AT masoodsepehrimanesh incidenceofulcerativecolitisrelapseaprospectivecohortstudyinsoutherniran AT alirezasafarpour incidenceofulcerativecolitisrelapseaprospectivecohortstudyinsoutherniran
_version_	1718428516715855872

Incidence of Ulcerative Colitis Relapse: A Prospective Cohort Study in Southern Iran

Ejemplares similares